Novo Nordisk Reports Data Theft as FulcrumSec Claims Hack

· Original article ↗

Summary

Novo Nordisk said hackers accessed internal IT systems and exfiltrated pseudonymized clinical-trial data. FulcrumSec claims it used a GitHub token to steal 1.3 TB, demanded $25 million, and threatens to leak it.

Key points

  • Novo Nordisk disclosed that hackers accessed internal IT systems and exfiltrated data associated with clinical trials.
  • The company said the stolen information was pseudonymized and could not be directly linked to patients by name or identifiers.
  • FulcrumSec claims it accessed the company in March using a GitHub access token, then cloned repositories and found additional credentials.
  • The group claims it stole about 1.3 TB of data and supplied a list of more than 700,000 files as proof.
  • Data the group says it stole allegedly includes undisclosed drug programs, compound structures, the Dicerna RNAi pipeline, and private AI models.
  • FulcrumSec demanded $25 million and is threatening to leak data; Novo Nordisk had not appeared on the group's Tor-based leak site at publication.

Article Details

Victim Organization
Novo Nordisk
Incident Type
Unauthorized access to internal IT systems and data exfiltration; FulcrumSec claimed responsibility.
Data Types Exposed
  • Pseudonymized data associated with clinical trials, reported by Novo Nordisk
  • Intellectual property, including undisclosed drug programs, proprietary compound structures, the Dicerna RNAi pipeline, and private AI models, allegedly stolen according to FulcrumSec
Affected Records
FulcrumSec provided a list of over 700,000 files as proof; the number of affected records was not disclosed.
Affected Data Size
FulcrumSec claimed it stole roughly 1.3 terabytes of data.
Operational Impact
Hackers accessed Novo Nordisk's internal IT systems. No further operational impact was reported.
Ransom Or Extortion
FulcrumSec demanded a $25 million ransom. The extortion attempt reportedly failed, and the group threatened to leak the allegedly stolen data. Novo Nordisk had not been listed on the group's Tor-based leak site at publication.
Claim Status
confirmed

Threat Actors

Products

Industries

Related Articles